SeraCare Life Sciences, Inc. (NASDAQ: SRLS) today announced that the Company will present at the Canaccord Genuity 30th Annual Global Growth Conference on Thursday, August 12, 2010 at 8:00 AM Eastern Time at the InterContinental Boston. Susan Vogt, President and CEO of SeraCare, will present an overview of the Company's business strategy, including core products and services and key initiatives that directly support SeraCare's global growth strategy. SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, validation and production of human diagnostics and therapeutics.

A live audio webcast and replay of the presentation will be available in the "Investor Relations, Events" section of the Company's website, www.seracare.com.

About SeraCare Life Sciences, Inc.:

SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics. The Company's innovative portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking and contract research services. SeraCare's quality systems, scientific expertise and state-of-the-art facilities support its customers in meeting the stringent requirements of the highly regulated life sciences industry.

SeraCare Life Sciences, Inc.
Gregory A. Gould, 508-244-6400
Chief Financial Officer
or
MacDougall Biomedical Communications
Sarah Cavanaugh, 781-235-3060